Can a CBD and THC mix pave the way for a new migraine therapy?
Knowledge-focused
Completed
This Phase 1 trial tests the safety and tolerability of S1-221, a liquid containing CBD and THC, when given as single rising doses to healthy adults aged 18 to 65. Researchers will monitor side effects, measure how the drug moves through the body, and check for any abuse-related …
Phase 1 • Sponsor: Delphian Therapeutics Australia Pty, Ltd • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC